Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion

被引：6

作者：

Aleppo, Grazia ^{[1
]}

Parkin, Christopher G. ^{[2
]}

Carlson, Anders L. ^{[3
,4
,5
]}

Galindo, Rodolfo J. ^{[6
,7
,8
]}

Kruger, Davida F. ^{[9
]}

Levy, Carol J. ^{[10
,11
,12
]}

Umpierrez, Guillermo E. ^{[13
,14
]}

Forlenza, Gregory P. ^{[15
]}

McGill, Janet B. ^{[16
]}

机构：

[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA

[2] CGParkin Commun Inc, Clin Res, 2352 Martinique Ave, Henderson, NV 89044 USA

[3] Regions Hosp & HealthPartners Clin, Int Diabet Ctr, Minneapolis, MN USA

[4] HealthPartners & Stillwater Med Grp, Diabet Educ Programs, Minneapolis, MN USA

[5] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

[6] Emory Univ, Sch Med, Atlanta, GA USA

[7] Emory Univ Hosp Midtown, Ctr Diabet Metab Res, Atlanta, GA USA

[8] Emory Healthcare Syst, Hosp Diabet Taskforce, Atlanta, GA USA

[9] Henry Ford Hlth Syst, Div Endocrinol Diabet Bone & Mineral, Detroit, MI USA

[10] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Metab, New York, NY 10029 USA

[11] Icahn Sch Med Mt Sinai, Mt Sinai Diabet Ctr, New York, NY 10029 USA

[12] Icahn Sch Med Mt Sinai, T1D Clin Res, New York, NY 10029 USA

[13] Emory Univ, Sch Med, Div Endocrinol Metab, Atlanta, GA USA

[14] Grady Mem Hosp, Diabet & Endocrinol, Atlanta, GA USA

[15] Univ Colorado Denver, Barbara Davis Ctr, Div Pediat Endocrinol, Dept Pediat, Denver, CO USA

[16] Washington Univ St Louis, Div Endocrinol Metab & Lipid Res, Sch Med, St Louis, MO USA

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷 / 10期

关键词：

CSII; AID; HCL; LGS; PLGS; Centers for Medicare & Medicaid Services; Insurance coverage; Type; 1; diabetes; 2; MULTIPLE DAILY INJECTIONS; GLUCOSE-SENSING TECHNOLOGY; IMPROVED GLYCEMIC CONTROL; PUMP THERAPY; C-PEPTIDE; DIABETES-MELLITUS; GLYCOSYLATED HEMOGLOBIN; TYPE-1; HYPOGLYCEMIA; ADHERENCE;

D O I：

10.1089/dia.2021.0196

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

引用

页码：715 / 725

页数：11

共 109 条

[1] Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia - a cross-sectional survey [J].